Cardioprecision |
|
Cardioprecision Ltd is an award-winning company, developing high quality medical devices for minimally invasive cardiovascular surgery. Currently its primary focus is on medical instrumentation dedicated to minimal access aortic valve replacement (AVR). Open heart AVR is the gold standard surgical treatment for advanced aortic calve disease. However, it requires splitting the breastbone (sternotomy). This inflicts significant patient trauma, requires extensive recuperation and may result in life-threatening complications. Therefore, there is a pressing need for innovation that allows surgical AVR to be performed minimally invasively. CadrioPrecision Ltd is developing a medical device to allow the surgeon to perform AVR through a small incision without sternotomy. This minimally invasive technology will cause less pain and lead to earlier mobilisation and recovery from surgery. It will not only improve the patients quality of life but also provide substantial economic savings to health service providers. This will be achieved through value-creating reductions in operating time, blood loss, transfusion requirements, infection rates, intensive care utilisation and hospital stay. For further information about CardioPrecision Ltd please contact: Dr Ying Sutherland (CEO) Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Telephone: +44 (0)7979236468 or Jim McGuire at Scottish Health Innovations Ltd. |